CoChat

The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance

Ahmed, Marwa N., Abdelsamad, Ahmed, Wassermann, Tina, Porse, Andreas, Becker, Janna, Sommer, Morten O. A., Høiby, Niels, Ciofu, Oana · 2020 · npj Biofilms and Microbiomes
Cited by 56

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Ciprofloxacin (CIP) is used to treat Pseudomonas aeruginosa biofilm infections. We showed that the pathways of CIP-resistance development during exposure of biofilms and planktonic P. aeruginosa populations to subinhibitory levels of CIP depend on the mode of growth. In the present study, we analyzed CIP-resistant isolates obtained from previous evolution experiments, and we report a variety of evolved phenotypic and genotypic changes that occurred in parallel with the evolution of CIP-resistance. Cross-resistance to beta-lactam antibiotics was associated with mutations in genes involved in cell-wall recycling (ftsZ, murG); and could also be explained by mutations in the TCA cycle (sdhA) genes and in genes involved in arginine catabolism. We found that CIP-exposed isolates that lacked mutations in quorum-sensing genes and acquired mutations in type IV pili genes maintained swarming motility and lost twitching motility, respectively. Evolved CIP-resistant isolates showed high fitness cost in planktonic competition experiments, yet persisted in the biofilm under control conditions, compared with ancestor isolates and had an advantage when exposed to CIP. Their persistence in biofilm competition experiments in spite of their fitness cost in planktonic growth could be explained by their prolonged lag-phase. Interestingly, the set of mutated genes that we identified in these in vitro-evolved CIP-resistant colonies, overlap with a large number of patho-adaptive genes previously reported in P. aeruginosa isolates from cystic fibrosis (CF) patients. This suggests that the antibiotic stress is contributing to the bacterial evolution in vivo, and that adaptive laboratory evolution can be used to predict the in vivo evolutionary trajectories.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41522-020-00138-8

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 41

  1. Andersson, D. I. & Hughes, D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12, 465–478 (2014). · DOI · Paper page
  2. Hughes, D. & Andersson, D. I. Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr. Opin. Microbiol. 15, 555–560 (2012). · DOI · Paper page
  3. Gullberg, E. et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS. Pathog. 7, e1002158 (2011). · DOI · Paper page
  4. Blazquez, J., Rodriguez-Beltran, J. & Matic, I. Antibiotic-induced genetic variation: how it arises and how it can be prevented. Annu. Rev. Microbiol. 72, 209–230 (2018). · DOI · Paper page
  5. Cirz, R. T., O’Neill, B. M., Hammond, J. A., Head, S. R. & Romesberg, F. E. Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J. Bacteriol. 188, 7101–7110 (2006). · DOI · Paper page
  6. Blazquez, J., Couce, A., Rodriguez-Beltran, J. & Rodriguez-Rojas, A. Antimicrobials as promoters of genetic variation. Curr. Opin. Microbiol. 15, 561–569 (2012). · DOI · Paper page
  7. Gocke, E. Mechanism of quinolone mutagenicity in bacteria. Mutat. Res. 248, 135–143 (1991). · DOI
  8. Jørgensen, K. M. et al. Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 57, 4215–4221 (2013). · DOI
  9. Wassermann, T. et al. The phenotypic evolution of Pseudomonas aeruginosa populations changes in the presence of subinhibitory concentrations of ciprofloxacin. Microbiology 162, 865–875 (2016). · DOI
  10. Hoiby, N. et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin. Microbiol. Infect. 21, S1–S25 (2015). · DOI · Paper page
  11. Rojo-Molinero, E., Macia, M. D. & Oliver, A. Social behavior of antibiotic resistant mutants within pseudomonas aeruginosa biofilm communities. Front. Microbiol. 10, 570 (2019). · DOI · Paper page
  12. Macia, M. D., Perez, J. L., Molin, S. & Oliver, A. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. Antimicrob. Agents Chemother. 55, 5230–5237 (2011). · DOI · Paper page
  13. Ahmed, M. N., Porse, A., Sommer, M. O. A., Hoiby, N. & Ciofu, O. Evolution of antibiotic resistance in biofilm and planktonic Pseudomonas aeruginosa populations exposed to subinhibitory levels of ciprofloxacin. Antimicrob. Agents Chemother. 62, e00320–18 (2018). · DOI · Paper page
  14. Ahmed, M. N. et al. Lack of the major multifunctional catalase KatA in Pseudomonas aeruginosa accelerates evolution of antibiotic resistance in ciprofloxacin-treated biofilms. Antimicrob. Agents Chemother. 63, e00766–19 (2019). · DOI
  15. Huse, H. K. et al. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. MBio 1(4), e00199–10 (2010). · DOI · Paper page
  16. Marvig, R. L., Sommer, L. M., Jelsbak, L., Molin, S. & Johansen, H. K. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients. Fut. Microbiol. 10, 599–611 (2015). · DOI
  17. Winstanley, C., O’Brien, S. & Brockhurst, M. A. Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections. Trends Microbiol. 24, 327–337 (2016). · DOI · Paper page
  18. Rehman, A., Patrick, W. M. & Lamont, I. L. Mechanisms of ciprofloxacin resistance in Pseudomonas aeruginosa: new approaches to an old problem. J. Med. Microbiol. 68, 1–10 (2019). · DOI · Paper page
  19. Santos-Lopez, A., Marshall, C. W., Scribner, M. R., Snyder, D. J., & Cooper, V. S. Evolutionary pathways to antibiotic resistance are dependent upon environmental structure and bacterial lifestyle. Elife. 8, e47612 (2019). · DOI · Paper page
  20. Frimodt-Moller, J. et al. Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts. Sci. Rep. 8, 12512 (2018). · DOI
  21. Jorth, P. et al. Evolved aztreonam resistance is multifactorial and can produce hypervirulence in Pseudomonas aeruginosa. MBio 8, e00517–17 (2017). · DOI
  22. Lopez-Causape, C., Cabot, G., Del Barrio-Tofino, E. & Oliver, A. The versatile mutational resistome of Pseudomonas aeruginosa. Front Microbiol. 9, 685 (2018). · DOI · Paper page
  23. Wardell, S. J. T. et al. A large-scale whole-genome comparison shows that experimental evolution in response to antibiotics predicts changes in naturally evolved clinical Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 63, e01619–19 (2019). · DOI
  24. Imamovic, L. et al. Drug-driven phenotypic convergence supports rational treatment strategies of chronic infections. Cell 172, 121–134 (2018). · DOI · Paper page
  25. Dunphy, L. J., Yen, P. & Papin, J. A. Integrated experimental and computational analyses reveal differential metabolic functionality in antibiotic-resistant Pseudomonas aeruginosa. Cell Syst. 8, 3–14 (2019). · DOI
  26. Fridman, O., Goldberg, A., Ronin, I., Shoresh, N. & Balaban, N. Q. Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations. Nature 513, 418–421 (2014). · DOI · Paper page
  27. Overhage, J., Bains, M., Brazas, M. D. & Hancock, R. E. Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J. Bacteriol. 190, 2671–2679 (2008). · DOI · Paper page
  28. Ha, D. G., Kuchma, S. L. & O’Toole, G. A. Plate-based assay for swarming motility in Pseudomonas aeruginosa. Methods Mol. Biol. 1149, 67–72 (2014). · DOI
  29. Hernando-Amado, S., Sanz-Garcia, F. & Martinez, J. L. Antibiotic resistance evolution is contingent on the quorum-sensing response in Pseudomonas aeruginosa. Mol. Biol. Evol. 36, 2238–2251 (2019). · DOI
  30. Cunin, R., Glansdorff, N., Pierard, A. & Stalon, V. Biosynthesis and metabolism of arginine in bacteria. Microbiol. Rev. 50, 314–352 (1986). · doi:10.1128/mr.50.3.314-352.1986 · Paper page
  31. Xiong, L. et al. Arginine metabolism in bacterial pathogenesis and cancer therapy. Int. J. Mol. Sci. 17, 363 (2016). · DOI
  32. Yang, L. et al. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl Acad. Sci. USA 108, 7481–7486 (2011). · DOI · Paper page
  33. Barraud, N. et al. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J. Bacteriol. 191, 7333–7342 (2009). · DOI · Paper page
  34. Olivares, P. J., Alvarez-Ortega, C., Alcalde,R. M., & Martinez, J. L. Metabolic compensation of fitness costs is a general outcome for antibiotic-resistant Pseudomonas aeruginosa mutants overexpressing efflux pumps. MBio 8, e00500–17 (2017). · DOI
  35. Crabbe, A., Jensen, P. O., Bjarnsholt, T. & Coenye, T. Antimicrobial tolerance and metabolic adaptations in microbial biofilms. Trends Microbiol. 27, 850–863 (2019). · DOI · Paper page
  36. Marvig, R. L. et al. Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients. BMC Microbiol. 15, 218 (2015). · DOI · Paper page
  37. Jørgensen, K. M. et al. Diversity of metabolic profiles of cystic fibrosis Pseudomonas aeruginosa during the early stages of lung infection. Microbiology 161, 1447–1462 (2015). · DOI
  38. Mathee, K. et al. Mucoid conversion of Pseudomonas aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the cystic fibrosis lung. Microbiology 145, 1349–1357 (1999). · DOI · Paper page
  39. Pribis, J. P. et al. Gamblers: an antibiotic-induced evolvable cell subpopulation differentiated by reactive-oxygen-induced general stress response. Mol. Cell 74, 785–800 (2019). · DOI · Paper page
  40. Kassen, R. & Rainey, P. B. The ecology and genetics of microbial diversity. Annu. Rev. Microbiol. 58, 207–231 (2004). · DOI · Paper page
  41. Marvig, R. L., Sommer, L. M., Molin, S. & Johansen, H. K. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis. Nat. Genet. 47, 57–64 (2015). · DOI · Paper page

Cited by

See all 56

Metadata

Authors
Ahmed, M. N., Abdelsamad, A., Wassermann, T., Porse, A., Becker, J., Sommer, M. O. A., Høiby, N., & Ciofu, O.
Venue
npj Biofilms and Microbiomes
Published
2020-07-24
Volume
6
Issue
1
ISSN
2055-5008
Cited by
56
References
2
Language
en
Licence
Funders
Novo Nordisk Fonden (NNF10CC1016517)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance. https://app.cochat.ai/papers/10.1038/s41522-020-00138-8
The paper
Ahmed, M. N., Abdelsamad, A., Wassermann, T., Porse, A., Becker, J., Sommer, M. O. A., Høiby, N., & Ciofu, O. (2020). The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance. npj Biofilms and Microbiomes. https://doi.org/10.1038/s41522-020-00138-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.